Evidence map›Paper›PMID 35845268›Full record

ArticleEJHaem2021

Bimodal expression of

Sylvie Galiègue-Zouitina, Qiangwei Fu, Céline Carton-Latreche, Nicolas Poret, Meyling Cheok, Frédéric Leprêtre, Martin Figeac, Bruno Quesnel, Hassiba El Bouazzati, Carl S Shelley

Open access · diamondAbstract read
In one paragraph

Article in EJHaem, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Bimodal expression ofEJHaem · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Sylvie Galiègue-ZouitinaJPARC UMRS 1172 Inserm Lille University Lille France.
Qiangwei FuCalifornia Institute for Biomedical Research La Jolla California USA.
Céline Carton-LatrecheJPARC UMRS 1172 Inserm Lille University Lille France.
Nicolas PoretJPARC UMRS 1172 Inserm Lille University Lille France.
Meyling CheokJPARC UMRS 1172 Inserm Lille University Lille France.
Frédéric LeprêtreUMS 2014 - US 41 Plateau de Génomique Fonctionnelle et Structurale Lille University Lille France.
Martin FigeacUMS 2014 - US 41 Plateau de Génomique Fonctionnelle et Structurale Lille University Lille France.
Bruno QuesnelJPARC UMRS 1172 Inserm Lille University Lille France.
Hassiba El BouazzatiJPARC UMRS 1172 Inserm Lille University Lille France.
Carl S ShelleyLLC Leukaemia Therapeutics Hull Massachusetts USA.ORCID https://orcid.org/0000-0001-7629-5376
Centre National de la Recherche Scientifique · FRInserm · FRUnité de Glycobiologie Structurale et Fonctionnelle · FRBlood Cancer UK · GBCalifornia Institute for Biomedical Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RhoH is an unusual member of the Rho family of small GTP-binding proteins in that it lacks GTPase activity. Since the RhoH protein is constantly bound by GTP, it is constitutively active and controlled predominantly by changes in quantitative expression. Abnormal levels of

Indexed as

AMLdifferentiation therapymyeloid differentiationRHOH

Identifiers

PMID35845268
PMCPMC9175762
OpenAlexW3122045750

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.